{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:19:21Z","timestamp":1779243561023,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:00:00Z","timestamp":1428710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:00:00Z","timestamp":1428710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0682-5","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:46:25Z","timestamp":1428626785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Sarah","family":"Prentice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily L","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel M","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison M","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Cose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,11]]},"reference":[{"key":"682_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","author":"BB Trunz","year":"2006","unstructured":"Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367:1173\u201380.","journal-title":"Lancet"},{"key":"682_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","volume":"346","author":"PE Fine","year":"1995","unstructured":"Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet. 1995;346:1339\u201345.","journal-title":"Lancet"},{"key":"682_CR3","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","volume":"375","author":"SH Kaufmann","year":"2010","unstructured":"Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet. 2010;375:2110\u20139.","journal-title":"Lancet"},{"key":"682_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/infdis\/jir244","volume":"204","author":"F Shann","year":"2011","unstructured":"Shann F. The nonspecific effects of vaccines and the expanded program on immunization. J Infect Dis. 2011;204:182\u20134.","journal-title":"J Infect Dis"},{"key":"682_CR5","first-page":"96","volume":"57","author":"JD Aronson","year":"1948","unstructured":"Aronson JD. BCG vaccination among American Indians. Am Rev Tuberc. 1948;57:96\u20139.","journal-title":"Am Rev Tuberc"},{"key":"682_CR6","first-page":"1336","volume":"31","author":"JD Aronson","year":"1948","unstructured":"Aronson JD. Protective vaccination against tuberculosis, with special reference to BCG vaccine. Minn Med. 1948;31:1336.","journal-title":"Minn Med"},{"key":"682_CR7","first-page":"517","volume":"53","author":"MI Levine","year":"1946","unstructured":"Levine MI, Sackett MF. Results of BCG immunization in New York City. Am Rev Tuberc. 1946;53:517\u201332.","journal-title":"Am Rev Tuberc"},{"key":"682_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/adc.2009.157537","volume":"95","author":"F Shann","year":"2010","unstructured":"Shann F. The non-specific effects of vaccines. Arch Dis Child. 2010;95:662\u20137.","journal-title":"Arch Dis Child"},{"key":"682_CR9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.28.4.622","volume":"28","author":"SR Rosenthal","year":"1961","unstructured":"Rosenthal SR, Loewinsohne, Graham ML, Liveright D, Thorne G, Johnson V. BCG vaccination against tuberculosis in Chicago. A twenty-year study statistically analyzed. Pediatrics. 1961;28:622\u201341.","journal-title":"Pediatrics"},{"key":"682_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0264-410X(01)00339-5","volume":"20","author":"ML Garly","year":"2001","unstructured":"Garly ML, Bale C, Martins CL, Balde MA, Hedegaard KL, Whittle HC, et al. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. Vaccine. 2001;20:468\u201374.","journal-title":"Vaccine"},{"key":"682_CR11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/bmj.321.7274.1435","volume":"321","author":"I Kristensen","year":"2000","unstructured":"Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ. 2000;321:1435\u20138.","journal-title":"BMJ"},{"key":"682_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1586\/14760584.5.2.277","volume":"5","author":"A Roth","year":"2006","unstructured":"Roth A, Garly ML, Jensen H, Nielsen J, Aaby P. Bacillus Calmette-Guerin vaccination and infant mortality. Expert Rev Vaccines. 2006;5:277\u201393.","journal-title":"Expert Rev Vaccines"},{"key":"682_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/ije\/dyh392","volume":"34","author":"A Roth","year":"2005","unstructured":"Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, Garly ML, et al. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol. 2005;34:540\u20137.","journal-title":"Int J Epidemiol"},{"key":"682_CR14","doi-asserted-by":"publisher","first-page":"c671","DOI":"10.1136\/bmj.c671","volume":"340","author":"AE Roth","year":"2010","unstructured":"Roth AE, Benn CS, Ravn H, Rodrigues A, Lisse IM, Yazdanbakhsh M, et al. Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ. 2010;340:c671.","journal-title":"BMJ"},{"key":"682_CR15","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1016\/j.vaccine.2006.03.033","volume":"24","author":"A Rodrigues","year":"2006","unstructured":"Rodrigues A, Fischer TK, Valentiner-Branth P, Nielsen J, Steinsland H, Perch M, et al. Community cohort study of rotavirus and other enteropathogens: are routine vaccinations associated with sex-differential incidence rates? Vaccine. 2006;24:4737\u201346.","journal-title":"Vaccine"},{"key":"682_CR16","first-page":"1197","volume":"23","author":"JE Veirum","year":"2005","unstructured":"Veirum JE, Sodemann M, Biai S, Jakobsen M, Garly ML, Hedegaard K, et al. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau. Guinea-Bissau Vaccine. 2005;23:1197\u2013204.","journal-title":"Guinea-Bissau Vaccine"},{"key":"682_CR17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","volume":"23","author":"LG Stensballe","year":"2005","unstructured":"Stensballe LG, Nante E, Jensen IP, Kofoed PE, Poulsen A, Jensen H, et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case\u2013control study. Vaccine. 2005;23:1251\u20137.","journal-title":"Vaccine"},{"key":"682_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","volume":"204","author":"P Aaby","year":"2011","unstructured":"Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis. 2011;204:245\u201352.","journal-title":"J Infect Dis"},{"key":"682_CR19","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1016\/j.vaccine.2009.06.103","volume":"27","author":"BM Kagina","year":"2009","unstructured":"Kagina BM, Abel B, Bowmaker M, Scriba TJ, Gelderbloem S, Smit E, et al. Delaying BCG vaccination from birth to 10\u00a0weeks of age may result in an enhanced memory CD4 T cell response. Vaccine. 2009;27:5488\u201395.","journal-title":"Vaccine"},{"key":"682_CR20","first-page":"956","volume":"3","author":"E Suciliene","year":"1999","unstructured":"Suciliene E, Ronne T, Plesner AM, Semenaite B, Slapkauskaite D, Larsen SO, et al. Infant BCG vaccination study in Lithuania. Int J Tuberc Lung Dis. 1999;3:956\u201361.","journal-title":"Int J Tuberc Lung Dis"},{"key":"682_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1136\/adc.67.1.80","volume":"67","author":"I Ildirim","year":"1992","unstructured":"Ildirim I, Sapan N, Cavusoglu B. Comparison of BCG vaccination at birth and at third month of life. Arch Dis Child. 1992;67:80\u20132.","journal-title":"Arch Dis Child"},{"key":"682_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2567.2002.01366.x","volume":"105","author":"GD Hussey","year":"2002","unstructured":"Hussey GD, Watkins ML, Goddard EA, Gottschalk S, Hughes EJ, Iloni K, et al. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology. 2002;105:314\u201324.","journal-title":"Immunology"},{"key":"682_CR23","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1164\/ajrccm\/140.4.1007","volume":"140","author":"HF Pabst","year":"1989","unstructured":"Pabst HF, Godel JC, Spady DW, McKechnie J, Grace M. Prospective trial of timing of bacillus Calmette-Guerin vaccination in Canadian Cree infants. Am Rev Respir Dis. 1989;140:1007\u201311.","journal-title":"Am Rev Respir Dis"},{"key":"682_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","volume":"168","author":"MO Ota","year":"2002","unstructured":"Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Sanneh M, Kidd M, et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol. 2002;168:919\u201325.","journal-title":"J Immunol"},{"key":"682_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1399-3038.2010.01051.x","volume":"21","author":"T Akkoc","year":"2010","unstructured":"Akkoc T, Aydogan M, Yildiz A, Karakoc-Aydiner E, Eifan A, Keles S, et al. Neonatal BCG vaccination induces IL-10 production by CD4+ CD25+ T cells. Pediatr Allergy Immunol. 2010;21:1059\u201363.","journal-title":"Pediatr Allergy Immunol"},{"key":"682_CR26","first-page":"635","volume":"32","author":"A Aggarwal","year":"1995","unstructured":"Aggarwal A, Dutta AK. Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity. Indian Pediatr. 1995;32:635\u20139.","journal-title":"Indian Pediatr"},{"key":"682_CR27","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.4049\/jimmunol.1000552","volume":"185","author":"S Burl","year":"2010","unstructured":"Burl S, Adetifa UJ, Cox M, Touray E, Ota MO, Marchant A, et al. Delaying bacillus Calmette-Guerin vaccination from birth to 4 1\/2\u00a0months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9\u00a0months of age. J Immunol. 2010;185:2620\u20138.","journal-title":"J Immunol"},{"key":"682_CR28","unstructured":"Higgins JPT S-WK, Reingold A. Systematic review of the non-specific effects of BCG, DTP and measles containing vaccines. In: WHO SAGE review. 2014."},{"key":"682_CR29","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.163.4.2249","volume":"163","author":"A Marchant","year":"1999","unstructured":"Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol. 1999;163:2249\u201355.","journal-title":"J Immunol"},{"key":"682_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2567.2007.02575.x","volume":"121","author":"J Madura Larsen","year":"2007","unstructured":"Madura Larsen J, Benn CS, Fillie Y, van der Kleij D, Aaby P, Yazdanbakhsh M. BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology. 2007;121:276\u201382.","journal-title":"Immunology"},{"key":"682_CR31","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1","volume":"31","author":"J Vekemans","year":"2001","unstructured":"Vekemans J, Amedei A, Ota MO, D\u2019Elios MM, Goetghebuer T, Ismaili J, et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol. 2001;31:1531\u20135.","journal-title":"Eur J Immunol"},{"key":"682_CR32","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/infdis\/jit570","volume":"209","author":"F Lutwama","year":"2014","unstructured":"Lutwama F, Kagina BM, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6\u00a0weeks of age in Ugandan infants. J Infect Dis. 2014;209:887\u201397.","journal-title":"J Infect Dis"},{"key":"682_CR33","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.vaccine.2012.01.053","volume":"30","author":"EJ Anderson","year":"2012","unstructured":"Anderson EJ, Webb EL, Mawa PA, Kizza M, Lyadda N, Nampijja M, et al. The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine. 2012;30:2083\u20139.","journal-title":"Vaccine"},{"key":"682_CR34","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.vaccine.2013.02.050","volume":"31","author":"A Andersen","year":"2013","unstructured":"Andersen A, Roth A, Jensen KJ, Erikstrup C, Lisse IM, Whittle H, et al. The immunological effect of revaccination with Bacille Calmette-Guerin vaccine at 19\u00a0months of age. Vaccine. 2013;31:2137\u201344.","journal-title":"Vaccine"},{"key":"682_CR35","doi-asserted-by":"publisher","first-page":"e14066","DOI":"10.1371\/journal.pone.0014066","volume":"5","author":"Y Djuardi","year":"2010","unstructured":"Djuardi Y, Sartono E, Wibowo H, Supali T, Yazdanbakhsh M. A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses. PLoS One. 2010;5:e14066.","journal-title":"PLoS One"},{"key":"682_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1224577","volume":"338","author":"H Drakesmith","year":"2012","unstructured":"Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012;338:768\u201372.","journal-title":"Science"},{"key":"682_CR37","first-page":"581","volume":"15","author":"JJ Bullen","year":"1968","unstructured":"Bullen JJ, Leigh LC, Rogers HJ. The effect of iron compounds on the virulence of Escherichia coli for guinea-pigs. Immunology. 1968;15:581\u20138.","journal-title":"Immunology"},{"key":"682_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-65502-9_1","volume":"60","author":"I Kochan","year":"1973","unstructured":"Kochan I. The role of iron in bacterial infections, with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol. 1973;60:1\u201330.","journal-title":"Curr Top Microbiol Immunol"},{"key":"682_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.virol.2007.06.011","volume":"367","author":"Z Debebe","year":"2007","unstructured":"Debebe Z, Ammosova T, Jerebtsova M, Kurantsin-Mills J, Niu X, Charles S, et al. Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Virology. 2007;367:324\u201333.","journal-title":"Virology"},{"key":"682_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0020-7519(01)00310-1","volume":"32","author":"T Breidbach","year":"2002","unstructured":"Breidbach T, Scory S, Krauth-Siegel RL, Steverding D. Growth inhibition of bloodstream forms of Trypanosoma brucei by the iron chelator deferoxamine. Int J Parasitol. 2002;32:473\u20139.","journal-title":"Int J Parasitol"},{"key":"682_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.exppara.2008.08.002","volume":"120","author":"AF Francisco","year":"2008","unstructured":"Francisco AF, de Abreu Vieira PM, Arantes JM, Pedrosa ML, Martins HR, Silva M, et al. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice. Exp Parasitol. 2008;120:314\u20139.","journal-title":"Exp Parasitol"},{"key":"682_CR42","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/cid\/cis010","volume":"54","author":"M Gwamaka","year":"2012","unstructured":"Gwamaka M, Kurtis JD, Sorensen BE, Holte S, Morrison R, Mutabingwa TK, et al. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin Infect Dis. 2012;54:1137\u201344.","journal-title":"Clin Infect Dis"},{"key":"682_CR43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1128\/IAI.50.3.932-934.1985","volume":"50","author":"PW Harvey","year":"1985","unstructured":"Harvey PW, Bell RG, Nesheim MC. Iron deficiency protects inbred mice against infection with Plasmodium chabaudi. Infect Immun. 1985;50:932\u20134.","journal-title":"Infect Immun"},{"key":"682_CR44","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1128\/AAC.06017-11","volume":"56","author":"A Fiori","year":"2012","unstructured":"Fiori A, Van Dijck P. Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis. Antimicrob Agents Chemother. 2012;56:3785\u201396.","journal-title":"Antimicrob Agents Chemother"},{"key":"682_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.fgb.2012.08.006","volume":"49","author":"J Kim","year":"2012","unstructured":"Kim J, Cho YJ, Do E, Choi J, Hu G, Cadieux B, et al. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs. Fungal Genet Biol. 2012;49:955\u201366.","journal-title":"Fungal Genet Biol"},{"key":"682_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/infdis\/119.1.11","volume":"119","author":"I Kochan","year":"1969","unstructured":"Kochan I. Mechanism of tuberculostasis in mammalian serum. I. Role of transferrin in human serum tuberculostasis. J Infect Dis. 1969;119:11\u20138.","journal-title":"J Infect Dis"},{"key":"682_CR47","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A. 2012;109:17537\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"682_CR48","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/00006454-199909000-00016","volume":"18","author":"CT D\u2019Angio","year":"1999","unstructured":"D\u2019Angio CT. Immunization of the premature infant. Pediatr Infect Dis J. 1999;18:824\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"682_CR49","first-page":"120","volume":"6","author":"J Mugalu","year":"2006","unstructured":"Mugalu J, Nakakeeto MK, Kiguli S, Kaddu-Mulindwa DH. Aetiology, risk factors and immediate outcome of bacteriologically confirmed neonatal septicaemia in Mulago hospital, Uganda. Afr Health Sci. 2006;6:120\u20136.","journal-title":"Afr Health Sci"},{"key":"682_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1590\/S0034-89102007000300001","volume":"41","author":"A Paiva Ade","year":"2007","unstructured":"Paiva Ade A, Rondo PH, Pagliusi RA, Latorre Mdo R, Cardoso MA, Gondim SS. Relationship between the iron status of pregnant women and their newborns. Rev Saude Publica. 2007;41:321\u20137.","journal-title":"Rev Saude Publica"},{"key":"682_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2334-5-115","volume":"5","author":"AM Elliott","year":"2005","unstructured":"Elliott AM, Namujju PB, Mawa PA, Quigley MA, Nampijja M, Nkurunziza PM, et al. A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guerin (BCG) immunisation ( ISRCTN328494470 . BMC Infect Dis. 2005;5:115.","journal-title":"BMC Infect Dis"},{"key":"682_CR52","doi-asserted-by":"publisher","first-page":"e47340","DOI":"10.1371\/journal.pone.0047340","volume":"7","author":"G Nkurunungi","year":"2012","unstructured":"Nkurunungi G, Lutangira JE, Lule SA, Akurut H, Kizindo R, Fitchett JR, et al. Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing. PLoS One. 2012;7:e47340.","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1186\/s13063-020-04594-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0682-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0682-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T09:50:54Z","timestamp":1691574654000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0682-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,11]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0682-5","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13063-020-04594-7","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,11]]},"assertion":[{"value":"28 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via the original article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"149"}}